Biotechnology
Health
Technology

Intrexon

$7.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.37 (5.57%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Intrexon and other stocks, options, ETFs, and crypto commission-free!

About XON

Intrexon Corporation Common Stock, also called Intrexon, is a biotechnology company, which engages in the research and development of synthetic biology technologies. It focuses on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. Read More The product pipeline includes Isobutanol, Isobutyraldehyde, Farnesene, and Isoprene. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Employees
882
Headquarters
Germantown, Maryland
Founded
1998
Market Cap
1.14B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.34M
High Today
$7.14
Low Today
$6.58
Open Price
$6.70
Volume
1.18M
52 Week High
$19.94
52 Week Low
$3.95

Collections

Biotechnology
Health
Technology
2013 IPO
US
North America

XON News

ReutersAug 10

Edited Transcript of XON earnings conference call or presentation 8-Aug-19 9:30pm GMT

32

XON Earnings

-$0.51
-$0.37
-$0.23
-$0.09
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.29 per share
Actual
-$0.25 per share

More XON News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.